Latanoprost

Overview

Latanoprost is a prostaglandin F2α analog used as an ophthalmic solution to lower intraocular pressure in glaucoma patients. It works by increasing the outflow of aqueous fluid from the eyes.

API suppliers (19)

Suppliers of Latanoprost evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• MSN Laboratories Private LimitedIndia1 active DMF GMP on record
• EUROAPI HUNGARY LTDHungary1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
• TAPI NL BVNetherlands1 active DMF
• FDC LimitedIndia1 active DMF GMP on record
• C-SQUARED PHARMA LTDUnited States1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
• CAYMAN PHARMA SROCzechia1 active DMF GMP on record
• DELTA BIOTECH SAArgentina1 active DMF
• KYOWA PHARMA CHEMICAL CO LTDJapan1 active DMF GMP on record
• GENTEC SABelgium1 active DMF
• NEWCHEM SPAItaly1 active DMF GMP on record
• Lupin LimitedIndia GMP on record
• RESOLUTION CHEMICALS LTD
• MYLAN LABORATORIES LTD GMP on record
• PATHEON API MANUFACTURING INC

EU CEP holders (13)

Companies holding a valid EU Certificate of Suitability (CEP) for Latanoprost, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (9 approved US products), the latest listed US patent on Latanoprost expires 8 Jul 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas